NanoString Technologies Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
NanoString Technologies Stock Forecast and Price Target
According to four esteemed experts, the average price target for NanoString Technologies to reach this year is $0.15, with a potential downside of approximately -44.44%. This prediction is based on a high estimate of $0.16 and a low estimate of $0.13. If you're considering investing in NSTG stock, it's essential to look at its competitors, too.
-44.44% Downside
NanoString Technologies Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Price for NanoString Technologies has grown by 100.00%, going from $0.00 to $0.00. In the coming year, analysts are expecting an increase in Fair Value, predicting it will reach $0.29 – an increase of 100.00%. Over the next seven years, experts anticipate that Fair Value growth for NanoString Technologies will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVGO Stock Forecast | Broadcom | Outperform |
8
|
$1.34k | Buy/Sell | $1.21k | 15.79% |
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$576.89 | Buy/Sell | $591.94 | 6.61% |
| NOVN Stock Forecast | Novartis | Hold |
10
|
CHF88.87 | Buy/Sell | CHF105.00 | 21.10% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF221.20 | Buy/Sell | CHF307.83 | 23.19% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$246.82 | Buy/Sell | $260.33 | 9.80% |
NanoString Technologies Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Revenue for NanoString Technologies has grown by 8.47%, going from $117.32M to $127.26M. In the coming year, analysts are expecting an increase in Revenue, predicting it will reach $205.55M – an increase of 61.52%. Over the next seven years, experts anticipate that Revenue growth for NanoString Technologies will be 303.74%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 6758 Stock Forecast | Sony Group | Buy |
6
|
¥12.77k | Buy/Sell | ¥16.23k | 26.08% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.44 | Buy/Sell | $284.47 | 18.87% |
| A Stock Forecast | Agilent Technologies | Outperform |
10
|
$139.59 | Buy/Sell | $138.82 | 8.53% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ILMN Stock Forecast | Illumina | Outperform |
16
|
$124.73 | Buy/Sell | $159.28 | 20.26% |
| HOLX Stock Forecast | Hologic | Outperform |
8
|
$76.63 | Buy/Sell | $81.06 | 9.62% |
| BRKR Stock Forecast | Bruker | Outperform |
16
|
$81.26 | Buy/Sell | $73.64 | 11.37% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NTRA Stock Forecast | Natera | Outperform |
7
|
$94.04 | Buy/Sell | $74.41 | 9.53% |
| TECH Stock Forecast | Bio-Techne Corp | Buy |
16
|
$64.51 | Buy/Sell | $100.78 | 24.01% |
| QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$42.30 | Buy/Sell | $0.00 | 18.20% |
NanoString Technologies EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, NanoString Technologies's EBITDA has grown, increasing from $-82.31M to $-144.37M – an increase of 75.40%. According to the 5 analysts polled, in the next year, NanoString Technologies's EBITDA will fall by 73.82%, reaching $-37.79M. By 2030, professionals believe that NanoString Technologies's EBITDA will have decreased by 129.91%, falling to $43.18M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$277.11 | Buy/Sell | $536.80 | 53.98% |
| 7701 Stock Forecast | Shimadzu | Outperform |
18
|
¥4.22k | Buy/Sell | ¥5.16k | 23.14% |
| TXG Stock Forecast | 10x Genomics | Outperform |
6
|
$28.40 | Buy/Sell | $58.14 | 83.10% |
NanoString Technologies EBIT Forecast for 2023 - 2025 - 2030
NanoString Technologies's EBIT has increased by 72.83% In the last two years, going from $-88.05M to $-152.18M. For the next year, 4 analysts project NanoString Technologies's EBIT to drop by 54.64%, reaching $-69.03M. By 2030, professionals believe that NanoString Technologies's EBIT will decrease by 123.98%, reaching $36.50M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 7731 Stock Forecast | Nikon | Hold |
8
|
¥1.61k | Buy/Sell | ¥1.73k | 5.75% |
| GH Stock Forecast | Guardant Health | Buy |
6
|
$18.19 | Buy/Sell | $43.00 | 141.89% |
| NEO Stock Forecast | NeoGenomics | Outperform |
8
|
$15.22 | Buy/Sell | $20.09 | 31.41% |
NanoString Technologies EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, EPS for NanoString Technologies has grown by 100.00%, going from $-2.60 to $0.00. In the coming year, analysts are expecting an increase in EPS, predicting it will reach $-1.18 – an increase of 100.00%. Over the next seven years, experts anticipate that EPS growth for NanoString Technologies will be 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VCYT Stock Forecast | Veracyte | Outperform |
11
|
$20.34 | Buy/Sell | $32.17 | 59.78% |
| CTKB Stock Forecast | Cytek Biosciences | Outperform |
2
|
$6.03 | Buy/Sell | $10.00 | 65.84% |
| OPK Stock Forecast | OPKO Health | Outperform |
8
|
$1.01 | Buy/Sell | $6.70 | 296.04% |
Site Navigation
.jpg)